Calcific tendinitis of the shoulder
Conditions
Interventions
Patients will be randomized to receive ESWT or NACD treatment. ESWT treatment:
patients will receive a focused ESWT. NACD treatment: a sonographically guided
removal of the calcific deposits will be
Sponsors
Maxima Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * age >18 years • calcifications on conventional x-rays O type I and II calcifications according to the Gärtner classification. O minimal diameter 10 mm on AP view • able and willing to comply to study protocol
Exclusion criteria
Exclusion criteria: * clinical signs of a frozen shoulder or adhesive capsulitis • operations of the affected shoulder in medical history * ESWT or NACD tretament during the last 6 months • full-thickness lesion of the rotator cuff tendon(s) on sonography • clinical and radiological signs of acute subacromial bursitis • clinical and radiological signs of acromioclavicular osteoarthritis • Rheumatic Arthritis or fibromyalgia • any contra-indications for the specific treatments (e.g. coagulopathies, malignancies in treated area) • other intra articular pathology: cartilage lesions, biceps pathology.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the between group differences in functional outcome (measured with the Constant-Murley Score) between baseline and 12 months follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. to assess the cost-effectiveness of both interventions over a period of 12 months. 2. to assess between group differences in change in pain scores, quality of life, adverse events and use of medications between baseline and 12 months follow-up. | — |
Countries
Netherlands
Outcome results
None listed